Originally published byEU-Startups
ScreenPoint Medical, a Nijmegen-based Breast AI company focusing on breast cancer detection and risk assessment, has raised €11.9 million ($14 million) in new funding from existing investors, global software investor Insight Partners and Siemens Healthineers. It has also secured €1.7 million ($2 million) in non-dilutive research grants. With this funding, the company aims to support […]
The post Insight Partners-backed ScreenPoint Medical secures €13.6 million to advance AI-powered breast cancer detection appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Securing the Untrusted Agentic Development Layer
1d ago
Inside Legora’s hunt for legal tech acquisitions
13h ago
The talent profile Europe's top AI scaleups are chasing
13h ago
Linux kernel maintainers pitch emergency killswitch after CopyFail and Dirty Frag chaos
2d ago
Feature freeze for Python 3.15 as first beta released
2d ago